An observational study in Cancer, Treatment-Related, sponsored by Institut Paoli-Calmettes. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-05-23.
Sponsored by Institut Paoli-Calmettes · Observational
study to correlate this level of objective physical activity with the levels of fatigue and quality of life in cancer patient being treated.
Study to objectify the level of physical activity of patients by a tool, often used in the global population: the pedometer. Several measurements per questionnaire also will be carried out repeatedly (weekly) in order to correlate this level of objective physical activity with the levels of fatigue and quality of life. The hypothesis we formulate is as follows: the number of weekly steps is negatively correlated with the level of fatigue, positively with the quality of life and well-being.
247 studies on the registry are indexed under Neoplasms, Second Primary; 48 are open to participants now.
This study's enrollment of 60 is below the median of 290 across 60 observational studies indexed under Neoplasms, Second Primary.
Browse Neoplasms, Second Primary studies →Institut Paoli-Calmettes is the lead sponsor of 168 studies on the registry; 50 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All cancer pathologies, all treatments. Provided that the patient is fit for walking.
Exclusion Criteria:
Patients in the GAR group will receive several recommendations and will have access to an online tool to increase motivation to engage in physical activity.
Device: Podometer
No recommendation given
Device: Podometer
Patients will be equipped with pedometers for 8 weeks, all day and must complete the number of steps each day. They will have to complete online evaluation questionnaires regularly. The main objective is to correlate the level of physical activity with the level of fatigue, quality of life and well-being weekly during an anticancer treatment.
Life satisfaction
Satisfaction With Life Scale (Blais et al, 1989, french-canadian validation, Revue Canadienne des Sciences du Comportement, 21(2), 210-223.)
Time frame: 2 months
Positive and negative affects measurement
Positive and Negative Affect Schedule (PANAS scales) (Caci et Baylé, 2007 First traduction in French, Congrès de l'Encéphale, Paris, 25-27 january 2007)
Time frame: 2 months
Fatigue
Multidimensional Inventory Fatigue : Gentile et al, 2003, Validation of the French multidimensional fatigue inventory (MFI 20), Eur J Cancer Care)
Time frame: 2 months
Quality of Life
European Organisation for Research and Treatment of Cancer Questionnaire Quality of Life version 30
Time frame: 2 months
Plan to share: No
This study is completed, as verified in May 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Institut Paoli-Calmettes